Drug Shortage Report for LORAZEPAM INJECTION USP

Last updated on 2021-03-02 History
Report ID 127901
Drug Identification Number 02388669
Brand name LORAZEPAM INJECTION USP
Common or Proper name Lorazepam Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) LORAZEPAM
Strength(s) 4MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 1mL vial
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-18
Estimated end date 2021-06-30
Actual end date
Shortage status Actual shortage
Updated date 2021-03-02
Company comments Inventory is on preventative allocation.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-03-02 French Compare
v6 2021-03-02 English Compare
v5 2020-12-21 French Compare
v4 2020-12-21 English Compare
v3 2020-12-16 English Compare
v2 2020-11-06 French Compare
v1 2020-11-06 English Compare